Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aubrey Anton"'
Autor:
Mark L. Bagarazzi, Ildiko Csiki, David Weiner, Rakesh Kumar, Mark Esser, Susan Duff, Sandra Oyola, Michael Dallas, Russell Vang, Drishty Mangrolia, Kelsie Dickerson, Aubrey Anton, Sophie Tan, Lindsay Sakata, Jean Boyer, Alexander Lin, Gregory S. Weinstein, Joshua M. Bauml, Dawson M. Knoblock, Albert J. Sylvester, Kimberly A. Kraynyak, Matthew P. Morrow, Roger B. Cohen, Charu Aggarwal
Supplemental Table 2: Number of patients in each cohort with any seroreactivity against the candidate antigens (HPV 16,18 E6 and E7) at (A) any timepoint following vaccination and (B) three months following final vaccination Supplemental Table 3: Flo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00eabed1abfd4b80f484b655c53dec8d
https://doi.org/10.1158/1078-0432.22472916.v1
https://doi.org/10.1158/1078-0432.22472916.v1
Autor:
Mark L. Bagarazzi, Ildiko Csiki, David Weiner, Rakesh Kumar, Mark Esser, Susan Duff, Sandra Oyola, Michael Dallas, Russell Vang, Drishty Mangrolia, Kelsie Dickerson, Aubrey Anton, Sophie Tan, Lindsay Sakata, Jean Boyer, Alexander Lin, Gregory S. Weinstein, Joshua M. Bauml, Dawson M. Knoblock, Albert J. Sylvester, Kimberly A. Kraynyak, Matthew P. Morrow, Roger B. Cohen, Charu Aggarwal
Purpose:Clinical responses with programmed death (PD-1) receptor–directed antibodies occur in about 20% of patients with advanced head and neck squamous cell cancer (HNSCCa). Viral neoantigens, such as the E6/E7 proteins of HPV16/18, are attractive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6796bfeadb07acc04de8d95a04654454
https://doi.org/10.1158/1078-0432.c.6528372
https://doi.org/10.1158/1078-0432.c.6528372
Autor:
Mark L. Bagarazzi, Ildiko Csiki, David Weiner, Rakesh Kumar, Mark Esser, Susan Duff, Sandra Oyola, Michael Dallas, Russell Vang, Drishty Mangrolia, Kelsie Dickerson, Aubrey Anton, Sophie Tan, Lindsay Sakata, Jean Boyer, Alexander Lin, Gregory S. Weinstein, Joshua M. Bauml, Dawson M. Knoblock, Albert J. Sylvester, Kimberly A. Kraynyak, Matthew P. Morrow, Roger B. Cohen, Charu Aggarwal
Supplemental legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51803170b0d9f9397e5106bcc930d031
https://doi.org/10.1158/1078-0432.22472922.v1
https://doi.org/10.1158/1078-0432.22472922.v1
Autor:
Aubrey Anton, Gregory S. Weinstein, Joshua Bauml, Albert Sylvester, Lindsay Sakata, Matthew P. Morrow, Kimberly A. Kraynyak, Mark L. Bagarazzi, Ildiko Csiki, Michael J. Dallas, Kelsie Dickerson, Roger B. Cohen, David B. Weiner, Mark T. Esser, Jean D. Boyer, Dawson Knoblock, Russell Vang, Alexander Lin, Rakesh Kumar, Charu Aggarwal, Susan Duff, Sophie Tan, Sandra Oyola, Drishty Mangrolia
Publikováno v:
Clinical Cancer Research. 25:110-124
Purpose: Clinical responses with programmed death (PD-1) receptor–directed antibodies occur in about 20% of patients with advanced head and neck squamous cell cancer (HNSCCa). Viral neoantigens, such as the E6/E7 proteins of HPV16/18, are attractiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185d078362ea6dfb406f8870236a7ad7
https://doi.org/10.1158/1078-0432.ccr-18-1763
https://doi.org/10.1158/1078-0432.ccr-18-1763
